ClinicalTrials.gg
RecruitingNCT07042386CROWNUpdated Sep 8, 2026

Implementation of a Beauty Salon-Based Strategy for Blood Pressure Management Among Women

An interventional study of CROWN Intervention and Enhanced Usual Care in Hypertension, sponsored by Johns Hopkins University. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
18 Years to 79 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 50 studies in Hypertension by Johns Hopkins University — 10 open to participants now, 14 under way, none of them phase 3. Hypertension · Johns Hopkins University.

Planned enrollment
21st of 44
144 · median 138
Started
2026
with 6 others
No phase
39 of 50
6 open now
Primary completion
2028-05
later than 11 of 13 live
Registered
43rd of 50
by date

Among the 50 studies in Hypertension by Johns Hopkins University, this one is the 21st largest by planned enrollment of the 44 interventional ones that give a count, is one of 7 that started in 2026, is one of 39 with no phase, reaches primary completion later than 11 of the 13 other live ones, and was the 43rd registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

10 of the 50 studies in Hypertension by Johns Hopkins University are open now, in 5 countries. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years to 79 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 50 studies in Hypertension by Johns Hopkins University, or all of them as a file.
02

Study summary

CROWN is a two-arm, cluster-randomized pilot trial testing the feasibility and preliminary efficacy of a salon-based cardiovascular intervention - training stylists as Heart Health Stylists to conduct in-salon blood pressure screenings, home monitoring with telehealth support, community health-worker coaching, and pharmacist-led medication management - among Black and Hispanic women with hypertension.

Read the detailed description

CROWN is a six-month, cluster-randomized pilot trial enrolling approximately 12 beauty salons. In intervention salons, trained Heart Health Stylists provide weekly private blood pressure screenings. Participants recruited from the intervention salons will receive a home blood pressure monitor linked to a mobile app, as well as community health worker coaching sessions and pharmacist medication support. Participants in the enhanced usual care salons will receive only printed educational materials and a home blood pressure monitor. Eligibility (age ≥18, self-identified Black or Hispanic, Systolic Blood Pressure (SBP) ≥130/80) will be confirmed via three standardized BP measurements, medical history review, and medication assessment in private salon alcoves or by phone. Assessments at baseline, 12, and 24 weeks include seated blood pressure (BP), weight, point-of-care hemoglobin A1c, and lipid panels, as well as surveys of health behaviors and social needs. Participants will receive gift cards, and retain the home monitor at the end of the study. The primary outcome is the change in systolic blood pressure; secondary outcomes include blood pressure control rates, adherence, lifestyle behaviors, and social needs resolution, with end-of-study qualitative interviews assessing acceptability.

03

Conditions studied

  • Hypertension

Browse trials for

Keywords

  • Hypertension
  • Implementation Science
  • Beauty Salon
  • Women
  • Community Based Intervention
  • Cardiovascular Disease Prevention
04

Who can participate

Ages eligible
18 Years to 79 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Women are eligible if:

  • At least 18 years old
  • Self-identify as Black/African American or Hispanic
  • Have an average seated systolic blood pressure of 130 mmHg or higher on initial salon screening, and
  • Have visited the participating salons at least twice in the past six months.

Exclusion criteria

Exclusion Criteria:

Women are excluded if:

  • Pregnant or planning pregnancy during the study period
  • Have end-stage renal disease requiring dialysis
  • Have serious medical conditions limiting to less than 12 months
  • Currently participating in other cardiovascular intervention studies
  • Have severe cognitive impairment, impeding
  • Unable to operate blood pressure monitoring equipment after training
  • Plan to relocate outside the study area within 6 months
  • Have documented adverse reactions to blood pressure cuff usage.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    CROWN Intervention Arm

    Participants will receive in-salon blood pressure screenings by trained stylists, a home blood pressure monitor connected to a telemonitoring app, community health worker coaching, pharmacist medication support, and digital social needs screening with referrals.

    Behavioral: CROWN Intervention

  • Active comparator
    Enhanced Usual Care Arm

    Participants will receive in-salon blood pressure screenings, a free Omron home monitor, printed cardiovascular health materials, and standard referrals to social and health services, without telemonitoring, coaching, or pharmacist support.

    Behavioral: Enhanced Usual Care

Interventions

  • BehavioralCROWN Intervention

    CROWN Intervention includes: 1. Private BP screenings in salon "Heart Health Stations" by trained Heart Health Stylists 2. Free Omron home BP monitor paired with a mobile app for twice-daily telemonitoring 3. In-depth coaching sessions + monthly check-ins with a community health worker 4. Bi-weekly medication review and adherence support by a clinical pharmacist 5. Digital social-needs screening (AHC HRSN) with referral to community resources

  • BehavioralEnhanced Usual Care

    Enhanced Usual Care include: 1. Private BP screenings in salon "Heart Health Stations" by Heart Health Stylists 2. Printed cardiovascular health brochures 3. Free home blood pressure monitor (no app integration) 4. Standard referrals to social and health services

06

What researchers measure

Primary outcomes

  1. Mean change in systolic blood pressure

    Mean change in systolic blood pressure as assessed by standardized American Heart Association (AHA)-guided automated measurements in the salon and at home (average of three seated readings after 5 minutes' rest).

    Time frame: Baseline, 3 months, 6 months

Secondary outcomes

  1. Change in Hemoglobin A1c

    Hemoglobin A1c by finger-stick point of care testing (POCT)

    Time frame: Baseline, 3 months, 6 months

  2. Change in weight, measured in pounds

    Change in weight via calibrated scales

    Time frame: Baseline, 3 months, 6 months

  3. Change in lipids level

    Change in lipids level by finger-stick point of care testing (POCT)

    Time frame: Baseline, 3 months, 6 months

  4. Change in Percent Body Fat

    Change in percent body fat via calibrated scales

    Time frame: Baseline, 3 months, 6 months

  5. Mean change in diastolic blood pressure

    Mean change in diastolic blood pressure as assessed by standardized American Heart Association (AHA)-guided automated measurements in the salon and at home (average of three seated readings after 5 minutes' rest).

    Time frame: Baseline, 3 months, 6 months

Other outcomes

  1. Change in Number of times health-related social resources were accessed

    Social resource utilization assessed by the AHC Health-Related Social Needs (HRSN) digital screening tool

    Time frame: Baseline, 3 months, 6 months

  2. Change in Health-related quality of life

    Measured with the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 instrument. Score ranges from 4-20, where a higher score correlates to better outcome.

    Time frame: Baseline, 6 months

  3. Change in Patient activation

    Assessed via the Patient Activation Measure-13 (PAM-13). Score of 0-100 where higher scores indicate a better outcome

    Time frame: Baseline, 6 months

  4. Change in Medication adherence

    Measured with the Hill-Bone Medication Adherence Scale. The total score ranges from 14 to 56. 14 is the worse adherence and 56 is the best adherence.

    Time frame: Baseline, 6 months

  5. Change in Self-efficacy

    Assessed using the New Self-Efficacy Scale (Score Range: 1-5; Higher scores are better)

    Time frame: Baseline, 6 months

  6. Implementation fidelity

    Implementation fidelity will be evaluated through adherence to intervention protocols. Reporting the number of salons that completed the study.

    Time frame: 6 months

  7. Implementation fidelity

    Implementation fidelity will be evaluated through adherence to intervention protocols. Reporting the number of deviations per salon.

    Time frame: 6 months

  8. Adoption

    Adoption will be measured by the proportion of invited salons and stylists who engage with the intervention.

    Time frame: 6 months

  9. Program Cost effectiveness

    Program costs, including expenses for stylist training, salon support, Community Health Worker (CHW) time, and technology infrastructure, will be tracked. Incremental Cost-Effectivness Ratio be reported. The ratio is the additional cost of one intervention compared to another, divided by the difference in their health outcomes.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for May 2028, 24 months after the start.

Of 1,407 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 24 months is close to that.

Counting every sponsor, half of 1,502 studies reached it within 23 months; a quarter within 10 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2025
First posted
Jun 29, 2025
StartActual
May 29, 2026
Primary completionEst.
May 31, 2028
CompletionEst.
May 31, 2028
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07042386
Collaborators
American Heart Association
Responsible party
Sponsor
First posted
Jun 29, 2025
Start date
May 29, 2026
Primary completion
May 31, 2028 (estimated)
Completion
May 31, 2028 (estimated)
Last update
Sep 8, 2026

Study contacts

Oluwabunmi Ogungbe, PhD, MPH, RN
Contact
oogungb3@jh.edu
4106141519
Yvonne Commodore-Mensah, PhD, MHS, RN
Contact
ycommod1@jhmi.edu
4106141519
Oluwabunmi Ogungbe, PhD, MPH, RN
principal investigator · Johns Hopkins School of Nursing

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion